Indermohan Thethi
Overview
Explore the profile of Indermohan Thethi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fareed J, Jeske W, Thethi I
Expert Opin Drug Metab Toxicol
. 2013 Jan;
9(3):307-17.
PMID: 23289968
Introduction: Antithrombotics are one of the most commonly prescribed classes of medication around the world. The thienopyridines are an integral part of antithrombotic therapy and are prescribed for various indications...
2.
Walenga J, Thethi I, Lewis B
Semin Thromb Hemost
. 2012 Aug;
38(8):884-92.
PMID: 22930343
The topic of adverse effects of drugs is now receiving due attention in both the lay and medical communities. For drugs of the coagulation disorder class, such as anticoagulants and...
3.
Griffin J, Hopkinson W, Lassen M, Thethi I, Litinas E, Fareed J
Clin Appl Thromb Hemost
. 2012 Feb;
17(6):567-71.
PMID: 22345625
Thromboembolic disease is a common complication of hip fracture in the elderly. Anticoagulants represent a standard of care in preventing postoperative thrombotic complications following surgical fixation. We asked whether levels...
4.
Thethi I, Bansal V, Khan H, Hoppensteadt D, Fareed J
Clin Appl Thromb Hemost
. 2012 Feb;
18(5):534-7.
PMID: 22311631
Patients with end-stage renal disease (ESRD) are known to have an elevation of a variety of abnormal thrombotic and inflammatory markers associated with high cardiovascular mortality. Vascular endothelial growth factor...
5.
Thethi I, Lewis B, Fareed J
J Burn Care Res
. 2012 Jan;
33(4):453-61.
PMID: 22269826
Oral anticoagulation used to be synonymous with warfarin until the recent approval of oral direct thrombin inhibitors and factor Xa inhibitors in United States and other countries across the world....
6.
De La Pena A, Fareed J, Thethi I, Morales-Vidal S, Schneck M, Shafer D
Clin Appl Thromb Hemost
. 2011 Nov;
18(3):324-6.
PMID: 22084414
Chronic immune thrombocytopenia (ITP) carries a poor prognosis in the elderly patients. Increasing evidence proposes that a subgroup of patients with chronic ITP may be more susceptible to ischemic stroke....
7.
Gomes M, Ramacciotti E, Henriques A, Araujo G, Szultan L, Miranda Jr F, et al.
Clin Appl Thromb Hemost
. 2011 Sep;
17(6):633-9.
PMID: 21949036
Introduction: Several generic low-molecular-weight heparins (LMWHs) have recently become available worldwide, including the United States. Companies have filed for regulatory approval of generic versions in many countries, based only on...
8.
Davis R, Bansal V, Litinas E, Hoppensteadt D, Thethi I, Nelson K, et al.
Clin Appl Thromb Hemost
. 2011 Aug;
17(6):E218-23.
PMID: 21873362
Systemic vascular changes contribute to both the pathogenesis and thrombotic comorbidities of end-stage renal disease (ESRD). This study aims to profile various biomarkers and better understand their role in the...
9.
Fareed J, Thethi I, Hoppensteadt D
Annu Rev Pharmacol Toxicol
. 2011 Aug;
52:79-99.
PMID: 21819239
Since the discovery of heparin nearly a century ago, there have been large gaps in the development of anticoagulants. The discovery of warfarin was the first step toward using oral...
10.
Rao G, Thethi I, Fareed J
Expert Rev Cardiovasc Ther
. 2011 Apr;
9(4):525-34.
PMID: 21517735
Coronary artery diseases leading to heart attacks and cerebral artery disease leading to stroke rank number one and two respectively, in causing acute vascular events. Thrombosis of the veins and...